Okay so the DEA is causing people with legitimate prescriptions to not have access to medication.
Are they doing anything about that? Seems like a very tractable problem.
Are they doing anything about that? Seems like a very tractable problem.
It does sound like the quota-setting system was designed for an era where the “legitimate” growth wasn’t on the order of “10% a year for 15 years”:
https://www.additudemag.com/adderall-shortage-dea-stimulants...
Instead of hoping for a Trump EO to nuke the DEA (literally or figuratively), why not redistribute Controlled Substance Act enforcement? Agencies like the FBI or HHS already handle overlapping domains. The DEA's rigid gatekeeping, especially on research and quotas, stifles innovation more than it curbs abuse.